Adherence Economics: The Real MSK Value in Payer Programs

Health plan leaders evaluating musculoskeletal (MSK) programs often encounter a compelling narrative of growth and innovation. However, a deeper, more instructive read emerges when focusing on the adherence economics record these programs keep. This distinction moves beyond headlines to examine what is documented, specifically within the frameworks of Accountable Care Organizations (ACOs) and Shared Savings Programs, providing a clearer lens for assessing true value in value-based care (VBC) arrangements.

The Foundational Documentation for Musculoskeletal Programs

For any musculoskeletal program to credibly participate in value-based care, it must first establish a documented record of its impact. This isn’t about projections or vendor claims, but rather a verifiable trail of how the program influences patient behavior and, consequently, clinical outcomes and cost. In the context of adherence economics, this means demonstrating how a program actively supports and measures patient adherence to recommended care pathways, in the end reducing downstream costs associated with non-adherence.

The core of this documentation revolves around the ability to track and report on metrics that directly correlate with patient engagement and sustained behavioral change. Without this foundational layer, any claims of cost reduction or improved health outcomes remain speculative. For health plans, this translates into a critical need to scrutinize not just what a program promises, but what it has demonstrably recorded. This recorded signal is paramount, especially when considering the integration of AI health platforms into VBC models. The expectation is that AI-driven interventions should not only be effective but also generate transparent, auditable data on patient adherence and its economic implications.

Accountable Care Organizations and the Shared Savings Program Mandate

The Centers for Medicare & Medicaid Services (CMS) established Accountable Care Organizations (ACOs) and their associated Shared Savings Programs to incentivize providers to deliver high-quality, coordinated care while reducing unnecessary costs. This framework inherently demands a rigorous approach to outcomes data and, importantly, a clear understanding of adherence economics. For a musculoskeletal program to contribute meaningfully to an ACO’s shared savings, its impact on patient adherence must be measurable and attributable. CMS ACO Shared Savings Program requirements

Within this context, the focus shifts from simply offering a service to demonstrating how that service drives measurable improvements in patient adherence, which then translates into quantifiable cost savings. ACOs are incentivized to reduce total cost of care while meeting quality targets, making programs that can document their contribution to both adherence and cost reduction particularly valuable. The documentation required for these programs goes beyond anecdotal evidence, demanding a strong data infrastructure capable of tracking patient journeys, intervention uptake, and clinical progression over time. This stringent requirement from CMS for documented savings and outcomes sets a high bar for any health technology, including AI-powered solutions, seeking to operate within these value-based frameworks.

Placing the Recorded Adherence Economics Set in Frame

When examining AI health platforms through the lens of adherence economics and the requirements of ACO Shared Savings Programs, certain vendors emerge with a documented record. This recorded set anchors on material that explicitly connects their interventions to patient adherence and the economic benefits derived from it. Hinge Health, Omada Health, and HeartFlow are examples of vendors whose materials, when scrutinized, connect to this adherence economics thread. It is important to note that this is not an endorsement of their financial performance or growth narratives, but rather an observation of their presence within the documented adherence economics record, particularly as it pertains to ACOs and Shared Savings Programs. Health Affairs analysis of digital health in VBC

For instance, Hinge Health, a digital MSK program, appears in this recorded set. The focus is on their ability to document how their platform influences patient adherence to physical therapy exercises and behavioral interventions, thereby reducing the need for more costly interventions like surgery or chronic pain management. Similarly, Omada Health, known for its digital chronic disease prevention and management programs, including those with MSK components, provides material that can be read through this adherence economics frame. Their documented impact often centers on sustained engagement and behavioral modification, leading to improved health outcomes and reduced healthcare utilization. HeartFlow, while operating in a different clinical domain (cardiac care), also provides an instructive parallel. Their AI-powered diagnostic tool, which aids in determining the need for invasive procedures, contributes to adherence economics by guiding patients toward the most appropriate, and often less invasive, care pathways, thereby optimizing resource utilization and potentially reducing costs. The common thread among these vendors is the existence of documented material that allows a health plan leader to trace the connection between their intervention, patient adherence, and the economic implications within a value-based care context.

“The true measure of an AI health platform in value-based care lies not in its technological sophistication alone, but in its verifiable contribution to patient adherence and the documented economic benefits that follow. Without this, it’s merely a promise, not a partnership.”

What a Reader Can Check Without a Vendor Conversation

For health plan leaders, the ability to independently verify claims is important. When assessing musculoskeletal programs, particularly those integrating AI, the adherence economics record provides a strong framework for independent evaluation. This means focusing on publicly available documentation, research, and reports that directly address the program’s impact on adherence and its financial implications within value-based payment models. National Library of Medicine research on digital health adherence

Instead of relying on vendor-provided performance figures or growth projections, health plan leaders can dig into published research, particularly that which has undergone peer review. Key areas to investigate include studies that demonstrate how a program:

• Increases patient engagement and retention over time.
• Reduces rates of non-adherence to prescribed therapies or lifestyle changes.
• Leads to a measurable decrease in downstream healthcare utilization, such as emergency room visits, specialist referrals, or surgical interventions, specifically linked to improved adherence.
• Provides transparent methodologies for tracking and reporting patient adherence data.

By focusing on the documented evidence of adherence economics, health plan leaders can move beyond marketing rhetoric and make informed decisions about which musculoskeletal programs genuinely align with the principles and requirements of value-based care. The instructive read is that a musculoskeletal program is read in the adherence economics record it keeps, not in a growth headline. That is the line between an adherence story and an adherence record.